Literature DB >> 193632

Levels of mammary tumor virus in hormone-dependent and -independent mouse mammary tumor cells.

M Sluyser, T Nouwen, J Hilgers, J Calafat.   

Abstract

Levels of mammary tumor virus particles (types A and B) and levels of the virus antigen were assayed in hormone-dependent and -independent mammary tumors of GR mice. Various transplant generations of seven separate tumor lines were investigated. The results indicated that the tumors consisted of different cell clones, each of which exhibited a separate progressive expression and subsequent loss of the mammary tumor virus. When the tumors were transplanted, levels of B particles first declined in the hormone-dependent cells, but in later transplant generations, the B particle content of the autonomous cells also dropped. In some tumor lines, this was accompanied by a decrease in viral antigens and/or A particles, but in other lines these concentrations remained high. One tumor line (line V) that remained hormone-dependent throughout nine transplantations was practically devoid of B particles but contained high levels of A particles and mammary tumor antigen.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 193632

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  The correlation between tissue differentiation and production of mammary tumor virus (MTV) in transplanted murine mammary tumors. Electron microscopic observations.

Authors:  C Schöpper; E Fasske; R Fetting; H Themann
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

2.  Selective amplification of mouse mammary tumor virus in mammary tumors of GR mice.

Authors:  T G Fanning; J P Puma; R D Cardiff
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

3.  Changes in concanavalin A-mediated agglutination of hormone-dependent mouse mammary tumour cells during serial transplantation.

Authors:  M Sluyser; M van der Valk; W J van Blitterswijk
Journal:  Br J Cancer       Date:  1980-03       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.